These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20549152)

  • 1. [In situ drug testing and adulterations. A response to Calafat, Juan and Duch (2009)].
    Vidal Giné C; Caudevilla Gálligo F; Ventura Vilamala M
    Adicciones; 2010; 22(2):173-4. PubMed ID: 20549152
    [No Abstract]   [Full Text] [Related]  

  • 2. [What is the use of pill testing?].
    Calafat A; Juan M; Duch MA
    Adicciones; 2010; 22(2):175-6. PubMed ID: 20549153
    [No Abstract]   [Full Text] [Related]  

  • 3. Straightforward single-calibrant quantification of seized designer drugs by liquid chromatography-chemiluminescence nitrogen detection.
    Rasanen I; Kyber M; Szilvay I; Rintatalo J; Ojanperä I
    Forensic Sci Int; 2014 Apr; 237():119-25. PubMed ID: 24631831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of seized emerging drugs by ultra-high performance liquid chromatography with photodiode array ultraviolet and mass spectrometric detection.
    Li L; Lurie IS
    Forensic Sci Int; 2014 Apr; 237():100-11. PubMed ID: 24607709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recreational drugs: the complication's pleasure?].
    Joye F; Donzé N; Frochaux V; Niquille M; Selz Amaudruz F
    Rev Med Suisse; 2013 Aug; 9(394):1454-60. PubMed ID: 24024389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative analysis of seized synthetic cannabinoids and synthetic cathinones by gas chromatography triple quadrupole tandem mass spectrometry.
    Gwak S; Arroyo-Mora LE; Almirall JR
    Drug Test Anal; 2015 Feb; 7(2):121-30. PubMed ID: 24827678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?
    Auwärter V; Dresen S; Weinmann W; Müller M; Pütz M; Ferreirós N
    J Mass Spectrom; 2009 May; 44(5):832-7. PubMed ID: 19189348
    [No Abstract]   [Full Text] [Related]  

  • 8. Designer drugs - A continuing chemical (R)evolution.
    Taffe MA; Olive MF
    Neuropharmacology; 2018 May; 134(Pt A):1-3. PubMed ID: 29605651
    [No Abstract]   [Full Text] [Related]  

  • 9. DART-MS in-source collision induced dissociation and high mass accuracy for new psychoactive substance determinations.
    Musah RA; Cody RB; Domin MA; Lesiak AD; Dane AJ; Shepard JR
    Forensic Sci Int; 2014 Nov; 244():42-9. PubMed ID: 25194642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pill testing or drug checking in Australia: Acceptability of service design features.
    Barratt MJ; Bruno R; Ezard N; Ritter A
    Drug Alcohol Rev; 2018 Feb; 37(2):226-236. PubMed ID: 28635057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of carryover in continuous flow systems.
    Hirst AD; Howorth PJ
    Ann Clin Biochem; 1975 Jan; 12(1):32. PubMed ID: 15637935
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification and characterization of a putative new psychoactive substance, 2-(2-(4-chlorophenyl)acetamido)-3-methylbutanamide, in Spain.
    Fabregat-Safont D; Fornís I; Ventura M; Gil C; Calzada N; Sancho JV; Hernández F; Ibáñez M
    Drug Test Anal; 2017 Jul; 9(7):1073-1080. PubMed ID: 28266810
    [No Abstract]   [Full Text] [Related]  

  • 13. [Contamination of illegal amphetamine. Hydrastatinine as a contaminant in 3,4-(methylenedioxy)methylamphetamine].
    Verweij AM
    Arch Kriminol; 1991; 188(1-2):54-7. PubMed ID: 1953248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In silico study on prediction of bioactivity for regulation of new designer drugs].
    Kurihara M
    Nihon Yakurigaku Zasshi; 2015 Dec; 146(6):315-20. PubMed ID: 26657122
    [No Abstract]   [Full Text] [Related]  

  • 15. Simultaneous determination of four designer drugs and their major metabolites by liquid chromatography-mass spectrometry.
    Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jun; 992():1-7. PubMed ID: 25939091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sterilization of eye-nose salves with gamma rays].
    Jacob BP; Leupin K
    Pharm Acta Helv; 1974; 49(1):12-20. PubMed ID: 4849770
    [No Abstract]   [Full Text] [Related]  

  • 17. Designer drugs--the Ecstasy and the agony.
    Kua EH
    Singapore Med J; 1997 Jan; 38(1):6. PubMed ID: 9269344
    [No Abstract]   [Full Text] [Related]  

  • 18. Doors of deception: the diaspora of designer drugs.
    Kerwin J
    Drug Test Anal; 2011 Sep; 3(9):527-31. PubMed ID: 21960538
    [No Abstract]   [Full Text] [Related]  

  • 19. [Identification of New Designer Benzodiazepine Diclazepam in Drug Facilitated Sexual Assault].
    Xiang P; Shen BH; Yan H; Liu W; Shen M; Wu HJ; Zhuo XY
    Fa Yi Xue Za Zhi; 2018 Jun; 34(3):248-252. PubMed ID: 30051661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure elucidation of a new designer benzylpiperazine: 4-bromo-2,5-dimethoxybenzylpiperazine.
    Westphal F; Junge T; Girreser U; Stobbe S; Pérez SB
    Forensic Sci Int; 2009 May; 187(1-3):87-96. PubMed ID: 19345524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.